Andrew Sinclair's most recent trade in Soleno Therapeutics Inc was a trade of 3,991 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Soleno Therapeutics Inc | Andrew Sinclair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 3,991 | 10,491 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Andrew Sinclair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 6,500 | 6,500 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Andrew Sinclair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Andrew Sinclair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Andrew Sinclair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Andrew Sinclair | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Mar 2022 | 7,720,000 | 7,720,000 | - | - | Warrant (right to buy) | |
| Soleno Therapeutics Inc | Andrew Sinclair | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Mar 2022 | 7,720,000 | 18,022,602 (40%) | 17% | - | Common Stock | |
| Soleno Therapeutics Inc | Andrew Sinclair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 31,862 | 31,862 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Andrew Sinclair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 40,000 | 40,000 | - | - | Employee stock option (right to buy) |